We are the investment arm of a single family office with its roots in the chemical and biopharmaceutical sectors.
We focus on investment solutions and opportunities, with a multi-asset orientation, and through a diverse array of fundamental and quantitative strategies deployed by selected specialists worldwide. The primary investment objective is to achieve attractive returns, while seeking to control the risk associated with specific investments.

We aim at federating family offices around the sharing of investment opportunities, allowing for greater access and execution in all investment fields. We primarily sponsor investments sourced from our internal researches, networks or structuring capabilities and then, eventually, form co-investor consortia around specific, selected opportunities.
IDS Capital S.A., headquartered in Geneva, Switzerland, and founded in 2004 is the Group holding company and specialises in quantitative research.

IDS Capital (UK) ltd, started its operation in August 2013 out of London, as an authorised and regulated Alternative Investment Fund Manager and MIFID regulated firm since 2016, under the supervision of the U.K. Financial Conduct Authority. All asset management or advisory activities are being handled by IDS Capital (UK) ltd.

Over its history, the firm has among others advised and invested in more than 500 hedge funds at all stages of development, in private equity and VC funds in multiple sectors and regions, structured specific access vehicles for various investment strategies in multiple juridiction and forms.